Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review
Nishant Munugala, Shishir K. Maithel, Rachna T. Shroff
HepatoBiliary Surgery and Nutrition (2021) Vol. 11, Iss. 2, pp. 253-266
Open Access | Times Cited: 16

Showing 16 citing articles:

Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model
Changcan Li, Bao Jin, Hang Sun, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version)
Han Wang, Jun Chen, Xin Zhang, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 11, Iss. 7, pp. 1553-1564
Open Access | Times Cited: 12
Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic Cholangiocarcinoma
Dai Zhang, Bao‐Ye Sun, Jing-Fang Wu, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 56-56
Open Access
Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis
Jiashuo Chao, Shanshan Wang, Hao Wang, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 11, pp. 3717-3726
Open Access | Times Cited: 8
Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase
Khac Cuong Bui, Mai Ly Thi Nguyen, Samarpita Barat, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 28, pp. 4534-4548
Closed Access | Times Cited: 2
Ex vivo liver resection and auto-transplantation and special systemic therapy in perihilar cholangiocarcinoma treatment
Konstantin Y Tchilikidi
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 3, pp. 635-640
Open Access | Times Cited: 2
L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression
Biqiang Zhu, Jingjing Zheng, Gaichao Hong, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 4
Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma
Baoluhe Zhang, Bao Jin, Xiangan Wu, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 1
Targeted therapies in hepatocellular carcinoma: past, present, and future
Rushabh Gujarathi, Joseph W. Franses, Anjana Pillai, et al.
Frontiers in Oncology (2024) Vol. 14
Closed Access | Times Cited: 1
The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment
Rocı́o I.R. Macı́as, Lorenza Rimassa, Ángela Lamarca
HepatoBiliary Surgery and Nutrition (2023) Vol. 12, Iss. 3, pp. 457-461
Open Access | Times Cited: 3
Brcaness in Biliary Tract Cancer: A New Prognostic and Predictive Biomarker?
Samir Hachem, Yara Kassis, Maria CR Hachem, et al.
Biomarkers in Medicine (2023) Vol. 17, Iss. 1, pp. 51-57
Closed Access | Times Cited: 2
Chemotherapy combined with targeted therapy and immunotherapy is an option in advanced biliary tract cancer
Penglei Ge, Yang Wu
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?
Iakovos Amygdalos, Ulf P. Neumann, Sven Arke Lang
HepatoBiliary Surgery and Nutrition (2023) Vol. 12, Iss. 4, pp. 631-633
Open Access
Renin-angiotensin system inhibitors improve the survival of cholangiocarcinoma: a propensity score-matched cohort study
Xiao‐Xu Zhu, Jianhui Li, Fang Peng, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access
New Insights into Surgical Management of Intrahepatic Cholangiocarcinoma in the Era of “Transplant Oncology”
Fabio Melandro, Davide Ghinolfi, Gaetano Gallo, et al.
Gastroenterology Insights (2023) Vol. 14, Iss. 3, pp. 406-419
Open Access
Unveiling the immunogenomic landscape of cholangiocarcinoma: Identifying new prognostic markers and therapeutic targets based on CCL5 expression
Jing Wang, Dan Xiang, Z. G. Dai, et al.
The Journal of Gene Medicine (2023) Vol. 26, Iss. 1
Closed Access
Page 1

Scroll to top